Regencell Bioscience (RGC) has had the highest return since August 31, 2024 by a US stock with a market cap of $400M+, returning 9,050.8%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,050.79% |
Bright Minds Biosciences (DRUG) | 5,814.95% |
Rigetti Computing (RGTI) | 4,673.91% |
Diginex Limited Ordinary Shares (DGNX) | 4,581.69% |
Mobilicom Limited Warrants (MOBBW) | 3,536.36% |
Monopar Therapeutics (MNPR) | 3,398.8% |
D-Wave Quantum (QBTS) | 3,169.31% |
Quantum Computing (QUBT) | 2,927.87% |
Oklo (OKLO) | 2,424.19% |
SS Innovations International Inc Common Stock (SSII) | 2,071.88% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 1,825.81% |
United States Antimony (UAMY) | 1,744.41% |
Mercurity Fintech Holding Inc ADR (MFH) | 1,546.79% |
Zepp Health (ZEPP) | 1,519% |
Microvast (MVST) | 1,372.79% |
Eos Energy Enterprises (EOSEW) | 1,084.62% |
Amprius Technologies (AMPX) | 1,014.95% |
Trilogy Metals (TMQ) | 984.1% |
Uniqure (QURE) | 964.97% |
Ondas (ONDS) | 959.77% |
Porch (PRCH) | 938.89% |
Rocket Lab USA (RKLB) | 936.45% |
IONQ (IONQ) | 867.81% |
Cidara Therapeutics (CDTX) | 860.49% |
Applied Digital (APLD) | 852.1% |
